Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter study

Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter study

Bibliographic Details
Main Authors: Yuliya Lytvyn, PhD, Hiba Zaaroura, MD, Asfandyar Mufti, MD, Shaikhah AlAbdulrazzaq, MD, Jensen Yeung, MD, FRCPC
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:JAAD International
Subjects:
biologic
drug survival
guselkumab
IL-23 inhibitor
Online Access:http://www.sciencedirect.com/science/article/pii/S266632872100033X

Internet

http://www.sciencedirect.com/science/article/pii/S266632872100033X

Similar Items